11 terminated. 11 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Terminated 11 |
| Phase 2 | 1 | Terminated 1 |
Follow Cellcept: new trials by email Literature Review of Cellcept trials Research Report on Cellcept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis Oral prednisolone, Rituximab, Mycophenolate mofetil - Systemic Lupus Erythematosus, Lupus Nephritis | Phase 3 | Terminated | Imperial College London | 24 | 2015-04-01 | 2018-02-01 |
| A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys Everolimus, Tacrolimus, Mycophenolate mofetil (MMF/MPA) - Delayed Graft Function | Phase 2 / Phase 3 | Terminated | Matthew Cooper | 25 | 2013-06-01 | 2019-04-26 |
| Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis BMS-188667, Mycophenolate mofetil, Prednisone - Lupus Nephritis | Phase 3 | Terminated | Bristol-Myers Squibb | 695 | 2013-01-22 | 2021-02-26 |
| Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) Treatment Cyclosporine combine with mycophenolate mofetil, Cyclophosphamide + pred - Anti-r-HuEpo Associated PRCA Subjects | Phase 3 | Terminated | Chulalongkorn University | 8 | 2009-01-01 | 2014-01-29 |
| Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML Allogeneic HSCT, Anti-thymocyte globulin (ATG), Cyclosporine (CSP) - Leukemia, Myeloid, Leukemia | Phase 3 | Terminated | Stanford University | 58 | 2007-08-01 | 2019-09-24 |
| A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . . Mycophenolate Mofetil, Mycofenolate Mofetil (MMF), Placebo - Interstitial Cystitis, Painful Bladder Syndrome | Phase 3 | Terminated | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 210 | 2007-03-01 | 2010-01-14 |
| A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis. Mycophenolate Mofetil, Corticosteroids, Azathioprine - Lupus Nephritis | Phase 3 | Terminated | Hoffmann-La Roche | 52 | 2007-03-01 | 2014-09-25 |
| A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis Mycophenolate mofetil (MMF), Cyclophosphamide, Maintenance Phase, Cyclophosphamide, Induction Phase - Lupus Nephritis | Phase 3 | Terminated | Hoffmann-La Roche | 16 | 2006-03-01 | 2014-07-17 |
| Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) mycophenolate mofetil, placebo - Cancer | Phase 3 | Terminated | Martin, Paul | 151 | 2004-05-01 | 2013-05-03 |
| Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation Mycophenolate mofetil, Tacrolimus - Evidence of Liver Transplantation | Phase 3 | Terminated | Rennes University Hospital | 195 | 2003-05-01 | 2012-07-04 |
| Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy Mycophenolate Mofetil (MMF), MMF Placebo, ACEi - IgA Nephropathy | Phase 3 | Terminated | St. Joseph's Hospital and Medical Center, Phoenix | 184 | 2002-01-01 | 2016-03-07 |
Lupus Nephritis (4) · AIDS-Related Complex (1) · Blast Crisis (1) · Breast Neoplasms (1) · Burkitt Lymphoma (1) · Carcinoma, Ovarian Epithelial (1) · Cystitis, Interstitial (1) · Delayed Graft Function (1) · Glomerulonephritis, IGA (1) · Graft vs Host Disease (1) · Inflammation (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Accelerated Phase (1)
Hoffmann-La Roche (2) · Bristol-Myers Squibb (1) · Chulalongkorn University (1) · Imperial College London (1) · Martin, Paul (1) · Matthew Cooper (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Rennes University Hospital (1) · St. Joseph's Hospital and Medical Center, Phoenix (1) · Stanford University (1)
United States (6) · Canada (3) · China (2) · Argentina (1) · Australia (1) · Brazil (1) · Chile (1) · Colombia (1) · Czechia (1) · France (1) · Hong Kong (1) · India (1) · Israel (1) · Italy (1) · Japan (1)
David Burks, MD (1) · Eric Bellissant, MD, PhD (1) · Harris Foster, MD (1) · John Kusek, PhD (1) · Karim Boudjema, MD, PhD (1) · Kearkiat Praditpornsilpa, MD (1) · LeRoy Nyberg, MD, PhD (1) · Liz Lightstone, Dr (1) · Matthew Cooper (1) · Paul J. Martin, MD (1) · Richard Landis, PhD (1) · Robert Lowsky (1) · Ronald J Hogg, M.D. (1)